NEC: Harnessing Artificial Intelligence-Powered Drug Development to Provide Tailored Medicines

NEC: harnessing artificial intelligence-powered drug development to provide tailored medicines

Individualized cancer therapies represent the next step for cancer immunotherapy. NEC Corporation has developed cutting-edge artificial intelligence to predict patient-specific neoantigens to turn this promise into reality and extend the approach to infectious diseases.

Cancer leaders lay out an optimistic vision for how AI will enhance patient care

AI in oncology will transform cancer care, experts say, helping match patients to trials, improve outcomes, support clinician decision-making

Digital Convergence AWS announced, during the Public Sector Symposium in Brazil, held this Thursday, 14/5, a partnership with the Hospital of the Clinics of the Federal University of Minas Gerais (HC-UFMG) and the UFMG Centre for Artificial Intelligence (CIA-Health) UFMG. The aim is to develop a cloud-based system and artificial intelligence to monitor and analyze the full day of patients with cancer, offering support to medical decisions.More...

Using AI to Enhance Cancer Diagnostics and Treatment

David Craig, PhD, discusses how AI is transforming cancer histopathology.